JP2025508548A5 - - Google Patents
Info
- Publication number
- JP2025508548A5 JP2025508548A5 JP2024553212A JP2024553212A JP2025508548A5 JP 2025508548 A5 JP2025508548 A5 JP 2025508548A5 JP 2024553212 A JP2024553212 A JP 2024553212A JP 2024553212 A JP2024553212 A JP 2024553212A JP 2025508548 A5 JP2025508548 A5 JP 2025508548A5
- Authority
- JP
- Japan
- Prior art keywords
- protein kinase
- composition
- kinase inhibitor
- additional therapeutic
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2022900578 | 2022-03-09 | ||
| AU2022900578A AU2022900578A0 (en) | 2022-03-09 | Treatment of clear cell renal carcinoma | |
| PCT/AU2023/050163 WO2023168491A1 (en) | 2022-03-09 | 2023-03-09 | Treatment of clear cell renal cell carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508548A JP2025508548A (ja) | 2025-03-26 |
| JP2025508548A5 true JP2025508548A5 (https=) | 2026-03-13 |
Family
ID=87936805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553212A Pending JP2025508548A (ja) | 2022-03-09 | 2023-03-09 | 淡明細胞型腎細胞癌の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250186438A1 (https=) |
| EP (1) | EP4489752A4 (https=) |
| JP (1) | JP2025508548A (https=) |
| KR (1) | KR20250099049A (https=) |
| CN (1) | CN119233819A (https=) |
| AU (1) | AU2023231023A1 (https=) |
| CA (1) | CA3245527A1 (https=) |
| WO (1) | WO2023168491A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120267672B (zh) * | 2025-06-11 | 2025-09-30 | 国科大杭州高等研究院 | 维生素c与酪氨酸激酶抑制剂联用在制备抗肾透明细胞癌药物中的应用及相关药物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112472699A (zh) * | 2013-07-26 | 2021-03-12 | 种族肿瘤学公司 | 改善比生群及衍生物的治疗益处的组合方法 |
| WO2019073296A1 (en) * | 2017-10-13 | 2019-04-18 | Race Oncology Ltd. | LIPOSOMAL FORMULATIONS OF BISANTRENE OR DERIVATIVES OR THE LIKE THEREOF |
| KR20210092204A (ko) * | 2018-10-04 | 2021-07-23 | 레이스 온콜로지 리미티드 | 비산트렌 제형의 제조 및 전달을 위한 방법 |
-
2023
- 2023-03-09 CN CN202380026367.8A patent/CN119233819A/zh active Pending
- 2023-03-09 KR KR1020247033654A patent/KR20250099049A/ko active Pending
- 2023-03-09 JP JP2024553212A patent/JP2025508548A/ja active Pending
- 2023-03-09 US US18/844,586 patent/US20250186438A1/en active Pending
- 2023-03-09 AU AU2023231023A patent/AU2023231023A1/en active Pending
- 2023-03-09 CA CA3245527A patent/CA3245527A1/en active Pending
- 2023-03-09 EP EP23765610.3A patent/EP4489752A4/en active Pending
- 2023-03-09 WO PCT/AU2023/050163 patent/WO2023168491A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3066101B1 (en) | Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors | |
| JP2024526145A5 (https=) | ||
| CN102089007B (zh) | (a)磷酸肌醇3-激酶抑制剂和(b)ras/raf/mek通路调节剂的组合产品 | |
| AR094654A1 (es) | Modulador del receptor de andrógeno y sus usos, método para tratamiento, composición farmacéutica | |
| ES2734081T3 (es) | Apilimod para el uso en el tratamiento de melanoma | |
| JP2001517250A (ja) | ナフタレンスルホン酸誘導体を含有する相乗作用抗腫瘍組成物 | |
| JP2024516795A5 (https=) | ||
| JP2024516363A5 (https=) | ||
| KR101628448B1 (ko) | 암 치료에 사용하기 위한 베무라페닙 및 인터페론을 포함하는 병용 요법 | |
| KR20230113594A (ko) | Pik3ca 돌연변이 암을 치료하기 위한 병용 요법 | |
| JP2025508548A5 (https=) | ||
| JP2016520662A (ja) | Ｐｉ３ｋ阻害剤および微小管不安定化剤の医薬組み合わせ | |
| JP2022500431A5 (https=) | ||
| BRPI0620242A2 (pt) | combinação compreendendo a combretastatina e agentes anti-cancerìgenos | |
| KR20050100676A (ko) | 아세틸살리실산 및 안지오텐신 ⅱ 길항제와 배합된디피리다몰의 뇌졸중 예방을 위한 용도 | |
| Zang et al. | Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer | |
| JP2025508548A (ja) | 淡明細胞型腎細胞癌の治療 | |
| JPH10167969A (ja) | 姑息的腫瘍療法でのドーパミンレセプター−アンタゴニストの使用 | |
| KR20120104574A (ko) | 티보자닙과 템시롤리무스의 조합물 | |
| JP2025511402A5 (https=) | ||
| JP2022500423A5 (https=) | ||
| AU2024343230A1 (en) | Combination of a wee1 inhibitor and a pkmyt1 inhibitor | |
| WO2026074499A1 (en) | Methods and compositions for inhibiting c-myc | |
| JP2012031140A (ja) | 骨髄異形性症候群を治療するための組成物および方法 | |
| JP2024506314A (ja) | がん治療のための併用療法 |